Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105
2020; Lippincott Williams & Wilkins; Volume: 38; Issue: 19 Linguagem: Inglês
10.1200/jco.19.02699
ISSN1527-7755
AutoresDawn L. Hershman, Joseph M. Unger, Grace Clarke Hillyer, Anna Moseley, Kathryn B. Arnold, Shaker R. Dakhil, Benjamin Esparaz, Ming C. Kuan, Mark L. Graham, Douglas M. Lackowski, William J. Edenfield, Zoneddy Dayao, N. Lynn Henry, Julie R. Gralow, Scott D. Ramsey, Alfred I. Neugut,
Tópico(s)Health Literacy and Information Accessibility
ResumoNonadherence to aromatase inhibitors (AIs) for breast cancer is common and increases the risk of recurrence. Text messaging increases adherence to medications for chronic conditions.
Referência(s)